AAVR disruption as a producer-cell engineering strategy for enhanced supernatant-based recovery of selected AAV serotypes

Molecular Therapy Advances · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles